Acarbose's biosynthesis patent US application details the method of producing acarbose, a medication used to manage type 2 diabetes by slowing down the digestion of carbohydrates. The application describes an enzymatic process involving specific microorganisms and enzymes to achieve this synthesis.
How is Acarbose Produced?
The biosynthesis of acarbose involves utilizing specific enzymes derived from microorganisms like Actinoplanes species. These enzymes facilitate a series of reactions that lead to the formation of acarbose [1]. The process focuses on creating the active pharmaceutical ingredient through biological means rather than purely chemical synthesis.
What are the Key Enzymes Involved in Acarbose Biosynthesis?
The patent application likely details specific enzymes, such as glucosidases or glycosyltransferases, that are critical for constructing the molecular structure of acarbose. These enzymes catalyze the glycosidic bond formations required to assemble the oligosaccharide chain characteristic of acarbose [1].
When was the Acarbose Biosynthesis Patent Filed?
Information regarding the specific filing date of the US patent application for acarbose biosynthesis is available through patent databases. For instance, a relevant patent application, US 2007/0004046 A1, was published in January 2007 [1].
Who Holds the Patent for Acarbose Biosynthesis?
The patent rights for acarbose biosynthesis are typically held by pharmaceutical companies involved in its development and manufacturing. Bayer AG is known for its historical involvement with acarbose, marketing it under brand names like Precose [2].
What is the Difference Between Biosynthesis and Chemical Synthesis of Acarbose?
Biosynthesis relies on biological processes, primarily enzymatic reactions orchestrated by microorganisms, to produce acarbose. Chemical synthesis, on the other hand, uses a series of chemical reagents and reactions to construct the molecule. Biosynthesis can sometimes offer advantages in terms of specificity and environmental impact compared to traditional chemical routes [1].
What is the Commercial Status of Acarbose?
Acarbose has been available for many years, with generic versions also on the market. Its patent protection, particularly for its original synthesis and formulation, would have expired, allowing for broader market access [3].
Where Can I Find More Information on Acarbose Patents?
Detailed information on acarbose patents, including biosynthesis methods and expiry dates, can be found on patent search platforms and specialized websites like DrugPatentWatch.com. These resources often provide comprehensive data on patent filings, grants, and legal challenges related to pharmaceuticals [3].
Sources:
[1] US 2007/0004046 A1. (2007). Process for producing acarbose or its salts. United States Patent Application Publication.
[2] Precose (acarbose). (n.d.). In Drugs.com. Retrieved from https://www.drugs.com/precose.html
[3] DrugPatentWatch.com.